The RNA inhibitor olpasiran significantly reduces a type of "bad cholesterol" that's associated with a high risk of ...

New research found that high levels of ‘good cholesterol’ in the blood were associated with an increased risk of glaucoma, an ...

Fact checked by Nick Blackmer A study found that typical cholesterol tests measuring HDL and LDL levels might be missing an ...

Roche announced its next generation assay received FDA 510(k) clearance for the measurement of lipoprotein(a) for assessment ...

Using hormone replacement therapy (HRT) to reduce cardiovascular risk during menopause remains a topic of debate. The ...

Researchers developed an epigenetic editing approach to silence the PCSK9 gene, achieving long-term cholesterol reduction ...

But there was one number that made cardiologists raise their eyebrows – her elevated lipoprotein(a), usually written Lp(a), which is more than five times the level that puts someone at ...

Findings of a new study suggest that the quality of LDL and HDL cholesterol, rather than their quantity, is more important in ...

Fluctuating LDL and total cholesterol levels in older adults may indicate increased dementia and cognitive decline risk.

The core of the lipoprotein, containing cholesterol ester and TG, is nonpolar and hydrophobic, and the outer layer of the lipoprotein particle (containing free cholesterol, phospholipid ...

Lerodalcibep is an adnectin-based, small protein-binding, third generation proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor.

High levels of variability in cholesterol over time were linked to a significantly higher risk for dementia and cognitive ...